Table 3.
Quality indicators of the type 2 diabetes program
| Treatment/screening | Quality indicator | % Patients |
|---|---|---|
| Normal growth | Percentage of patients with height below the 3rd percentile | 0 |
| Physical development | Average BMI in diabetic children | 36.8 kg/m2 |
| Percentage of patients with BMI above the 85th percentile | 100 | |
| Normal pubertal development | Mean age at menarche in girls with diabetes | 11.6±1.7 years |
| Low rate of acute complications | Frequency of severe hypoglycemia in all patients | 0 |
| Frequency of admission because of diabetic ketoacidosis after onset of diabetes | 0 | |
| Prevention of microvascular complications | Percentage of patients with eye examinations during the past year | 100 |
| Percentage of patients with urine albumin excretion rate determined during the past year | 88 | |
| Mean HbA1c achieved in all patients | 6.4%±0.9% | |
| Percentage of patients beyond 5 years of diabetes with diabetic retinopathy | NA | |
| Percentage of patients beyond 5 years of diabetes with diabetic nephropathy | NA | |
| Percentage of patients with persistent microalbuminuria not receiving ACEI (or other interventions for microalbuminuria) | 0 | |
| Percentage of patients with lipid levels available during the past year | 100 | |
| Prevention of cardiovascular complications | Percentage of patients with blood pressure recordings available during the past year | 100 |
| Percentage of patients with hypertension | 29.4 | |
| Percentage of patients with hyperlipidemia | 70.6 | |
| Percentage of patients with hypertension not receiving antihypertensive therapy | 0 | |
| Percentage of patients with hypertension not receiving lipid-lowering therapy | 100 | |
| Screening for other comorbidities | Percentage of patients screened for non-alcoholic fatty liver disease | 100 |
| Percentage of patients screened for obstructive sleep apnea | 100 | |
| Percentage of female patients screened for polycystic ovary syndrome | 100 | |
| Optimal social adjustment | Average number of days spent in hospital post diagnosis | 0 |
| Percentage of patients on flexible insulin regimen (beyond remission) | 11.8 | |
| Percentage of visits annually | Percentage of visits attended per year | 74 physician 67 non-physician |
| Screening for other comorbidities | Percentage of patients screened for non-alcoholic fatty liver disease | 100 |
| Percentage of patients screened for obstructive sleep apnea | 100 | |
| Percentage of female patients screened for polycystic ovary syndrome | 100 |
Abbreviations: BMI, body mass index; HbA1c, glycated hemoglobin; NA, not applicable; ACEI, angiotensin-converting enzyme inhibitor.